Cargando…

Improved ADM Penetration Distance and Therapeutic Efficiency in a Rabbit VX2 Liver Cancer Model by Relaxin Infusion Combined with Transcatheter Chemoembolization Through Hepatic Artery

PURPOSE: To evaluate the adriamycin (ADM) pervasion distance within tumor stroma after relaxin (RLX) infusion through tumor feeding artery and further investigate the therapeutic effects of RLX infusion combined with transcatheter chemoembolization (TACE) on the rabbit VX2 liver cancer, since the ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Fu, Cao, Yanyan, Guo, Xiaopeng, Zhang, Hongsen, Wang, Jihua, Xiong, Bin, Liang, Bin, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231763/
https://www.ncbi.nlm.nih.gov/pubmed/32494202
http://dx.doi.org/10.2147/CMAR.S223993
_version_ 1783535246040367104
author Xiong, Fu
Cao, Yanyan
Guo, Xiaopeng
Zhang, Hongsen
Wang, Jihua
Xiong, Bin
Liang, Bin
Zheng, Chuansheng
author_facet Xiong, Fu
Cao, Yanyan
Guo, Xiaopeng
Zhang, Hongsen
Wang, Jihua
Xiong, Bin
Liang, Bin
Zheng, Chuansheng
author_sort Xiong, Fu
collection PubMed
description PURPOSE: To evaluate the adriamycin (ADM) pervasion distance within tumor stroma after relaxin (RLX) infusion through tumor feeding artery and further investigate the therapeutic effects of RLX infusion combined with transcatheter chemoembolization (TACE) on the rabbit VX2 liver cancer, since the chemotherapy impaired due to limited drug distribution hindered by stiffened tumor stroma. MATERIALS AND METHODS: In the first part, rabbits received normal saline (NS), RLX or combined with TACE, and the penetration distance of ADM was measured by immunofluorescence and the matrix metalloproteinases (MMPs) were evaluated by gelatin substrate zymography in each group. In the second part, the rabbits received NS, TACE and RLX combined with TACE, respectively. The tumor growth rates, necrosis rates and intrahepatic metastasis were measured, and hematoxylin-eosin (HE), transferase-mediated dUTP-biotin nick end labelling (TUNEL) and Ki67 staining were conducted in each group. RESULTS: In the first part, the expression of MMP-9 was increased in groups treated by RLX compared with NS group, especially three days after RLX infusion (p=0.001). The ADM penetration distance was significantly increased in groups treated by RLX compared with NS group (p<0.05), and it was farthest three days after RLX infusion. In the second part, compared with the NS and TACE groups, the tumor growth rates, the positive staining rates of Ki67 and the tumor growth rates were significantly decreased in RLX+TACE group (p<0.05). However, the positive staining rates of TUNEL and the tumor necrosis rates were significantly increased (p<0.05), and HE staining also revealed higher necrosis rates. The intrahepatic metastasis indicates no difference between the three groups (p=0.273). CONCLUSION: An increased penetration distance was obtained by RLX infusion through tumor feeding artery, and better therapeutic effects were achieved by RLX combined with TACE.
format Online
Article
Text
id pubmed-7231763
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72317632020-06-02 Improved ADM Penetration Distance and Therapeutic Efficiency in a Rabbit VX2 Liver Cancer Model by Relaxin Infusion Combined with Transcatheter Chemoembolization Through Hepatic Artery Xiong, Fu Cao, Yanyan Guo, Xiaopeng Zhang, Hongsen Wang, Jihua Xiong, Bin Liang, Bin Zheng, Chuansheng Cancer Manag Res Original Research PURPOSE: To evaluate the adriamycin (ADM) pervasion distance within tumor stroma after relaxin (RLX) infusion through tumor feeding artery and further investigate the therapeutic effects of RLX infusion combined with transcatheter chemoembolization (TACE) on the rabbit VX2 liver cancer, since the chemotherapy impaired due to limited drug distribution hindered by stiffened tumor stroma. MATERIALS AND METHODS: In the first part, rabbits received normal saline (NS), RLX or combined with TACE, and the penetration distance of ADM was measured by immunofluorescence and the matrix metalloproteinases (MMPs) were evaluated by gelatin substrate zymography in each group. In the second part, the rabbits received NS, TACE and RLX combined with TACE, respectively. The tumor growth rates, necrosis rates and intrahepatic metastasis were measured, and hematoxylin-eosin (HE), transferase-mediated dUTP-biotin nick end labelling (TUNEL) and Ki67 staining were conducted in each group. RESULTS: In the first part, the expression of MMP-9 was increased in groups treated by RLX compared with NS group, especially three days after RLX infusion (p=0.001). The ADM penetration distance was significantly increased in groups treated by RLX compared with NS group (p<0.05), and it was farthest three days after RLX infusion. In the second part, compared with the NS and TACE groups, the tumor growth rates, the positive staining rates of Ki67 and the tumor growth rates were significantly decreased in RLX+TACE group (p<0.05). However, the positive staining rates of TUNEL and the tumor necrosis rates were significantly increased (p<0.05), and HE staining also revealed higher necrosis rates. The intrahepatic metastasis indicates no difference between the three groups (p=0.273). CONCLUSION: An increased penetration distance was obtained by RLX infusion through tumor feeding artery, and better therapeutic effects were achieved by RLX combined with TACE. Dove 2020-05-13 /pmc/articles/PMC7231763/ /pubmed/32494202 http://dx.doi.org/10.2147/CMAR.S223993 Text en © 2020 Xiong et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Xiong, Fu
Cao, Yanyan
Guo, Xiaopeng
Zhang, Hongsen
Wang, Jihua
Xiong, Bin
Liang, Bin
Zheng, Chuansheng
Improved ADM Penetration Distance and Therapeutic Efficiency in a Rabbit VX2 Liver Cancer Model by Relaxin Infusion Combined with Transcatheter Chemoembolization Through Hepatic Artery
title Improved ADM Penetration Distance and Therapeutic Efficiency in a Rabbit VX2 Liver Cancer Model by Relaxin Infusion Combined with Transcatheter Chemoembolization Through Hepatic Artery
title_full Improved ADM Penetration Distance and Therapeutic Efficiency in a Rabbit VX2 Liver Cancer Model by Relaxin Infusion Combined with Transcatheter Chemoembolization Through Hepatic Artery
title_fullStr Improved ADM Penetration Distance and Therapeutic Efficiency in a Rabbit VX2 Liver Cancer Model by Relaxin Infusion Combined with Transcatheter Chemoembolization Through Hepatic Artery
title_full_unstemmed Improved ADM Penetration Distance and Therapeutic Efficiency in a Rabbit VX2 Liver Cancer Model by Relaxin Infusion Combined with Transcatheter Chemoembolization Through Hepatic Artery
title_short Improved ADM Penetration Distance and Therapeutic Efficiency in a Rabbit VX2 Liver Cancer Model by Relaxin Infusion Combined with Transcatheter Chemoembolization Through Hepatic Artery
title_sort improved adm penetration distance and therapeutic efficiency in a rabbit vx2 liver cancer model by relaxin infusion combined with transcatheter chemoembolization through hepatic artery
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231763/
https://www.ncbi.nlm.nih.gov/pubmed/32494202
http://dx.doi.org/10.2147/CMAR.S223993
work_keys_str_mv AT xiongfu improvedadmpenetrationdistanceandtherapeuticefficiencyinarabbitvx2livercancermodelbyrelaxininfusioncombinedwithtranscatheterchemoembolizationthroughhepaticartery
AT caoyanyan improvedadmpenetrationdistanceandtherapeuticefficiencyinarabbitvx2livercancermodelbyrelaxininfusioncombinedwithtranscatheterchemoembolizationthroughhepaticartery
AT guoxiaopeng improvedadmpenetrationdistanceandtherapeuticefficiencyinarabbitvx2livercancermodelbyrelaxininfusioncombinedwithtranscatheterchemoembolizationthroughhepaticartery
AT zhanghongsen improvedadmpenetrationdistanceandtherapeuticefficiencyinarabbitvx2livercancermodelbyrelaxininfusioncombinedwithtranscatheterchemoembolizationthroughhepaticartery
AT wangjihua improvedadmpenetrationdistanceandtherapeuticefficiencyinarabbitvx2livercancermodelbyrelaxininfusioncombinedwithtranscatheterchemoembolizationthroughhepaticartery
AT xiongbin improvedadmpenetrationdistanceandtherapeuticefficiencyinarabbitvx2livercancermodelbyrelaxininfusioncombinedwithtranscatheterchemoembolizationthroughhepaticartery
AT liangbin improvedadmpenetrationdistanceandtherapeuticefficiencyinarabbitvx2livercancermodelbyrelaxininfusioncombinedwithtranscatheterchemoembolizationthroughhepaticartery
AT zhengchuansheng improvedadmpenetrationdistanceandtherapeuticefficiencyinarabbitvx2livercancermodelbyrelaxininfusioncombinedwithtranscatheterchemoembolizationthroughhepaticartery